Implication of hepatic sinusoidal cells in pathophysiology of the liver diseases and development of novel therapeutic strategies

肝窦细胞在肝脏疾病病理生理学中的意义及新治疗策略的开发

基本信息

  • 批准号:
    06454383
  • 负责人:
  • 金额:
    $ 4.61万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
  • 财政年份:
    1994
  • 资助国家:
    日本
  • 起止时间:
    1994 至 1995
  • 项目状态:
    已结题

项目摘要

1. Mechanism on endotoxin-induced liver injury. We clarified that ICAM-1 expression in the hepatic sinusoidal endothelial cell (SEC) was increased and then such increase was inhibited by a blockade of hepatic macrophages in endotoxin-injected rats. Also, we showed the amelioration of endotoxin-induced liver injury in the leucocytes-depletion rats. These evidence suggested the causative role of the interaction among hepatic macrophage, adhesion molecule and leucocytes in this injury. Furthermore, we identified thromboxane (TX) A_2 receptor (R) on SEC and showed pathogenic implication of TXA_2-TXA_2R system in endotoxin-induced and cold preservation/reperfusion liver injury.2. Pathogenesis of cold preservation-reperfusion liver injury. We found that hepatic macrophage is at priming state in the cold preservation of the liver. Then, it was shown that a blockade of hepatic macrophage suppressed intrasinusoidal coagulation and leucocyte adhesion in the liver, leading to the inhibition of hepatic microcirculatory disturbance.3. Expression of the Na^+/Ca^<++> exchanger in activated Ito cells. We demonstrated first that Na^+/Ca^<++> exchanger, which is a transporter protein that couples the translocation of Ca^<++> to that of Na^+ in the opposite direction and contribute to the maintenance of intracelluler Ca^<++> homeostasis, is expressed in Ito cells in association with liver fibrosis.4. Identification of kan-1 and its clinical implication. We identified a novel gene, kan-1 in the rat liver using an RNA-PCR cloning strategy. By cross-hybridyzation with a rat kan-1 cDNA probe, we obtained a cDNA clone from a human liver cDNA library. This is found to be identical to bile acid CoA : amino acid N-acyltransferase. We showed that kan-1 is a novel predictive indicator for prognosis of hepatoma patients.
1。内毒素诱导的肝损伤的机制。我们澄清说,肝弦正弦内皮细胞(SEC)中的ICAM-1表达增加了,然后在注入内毒素的大鼠中阻断肝巨噬细胞的封锁抑制了这种增加。另外,我们显示了内毒素诱导的肝损伤在白细胞止血大鼠中的改善。这些证据表明,肝巨噬细胞,粘附分子和白细胞在这种损伤中相互作用的作用。此外,我们在SEC上确定了血栓烷(TX)A_2受体(R),并显示了TXA_2-TXA_2R系统在内毒素诱导的和冷保存/再灌注肝损伤中的致病意义。2。冷保存重新灌注肝损伤的发病机理。我们发现,肝巨噬细胞处于肝脏冷保存中的启动状态。然后,结果表明,肝巨噬细胞的阻塞抑制了肝脏内侧内凝结和白细胞粘附,导致肝微循环障碍的抑制。3。激活的ITO细胞中Na^+/Ca^<++>交换器的表达。我们首先证明了Na^+/ca^<++>交换器,它是一种转运蛋白,将Ca^<++>的易位沿相反方向耦合到Na^+的转运,并有助于维持纤维内Ca ^<++>稳态,在ITO细胞中与肝纤维化相关。4。 KAN-1及其临床意义的识别。我们使用RNA-PCR克隆策略确定了大鼠肝脏中的新基因KAN-1。通过用大鼠KAN-1 cDNA探针交叉杂交杂志,我们从人肝cDNA文库中获得了cDNA克隆。发现这与胆汁酸COA相同:氨基酸N-酰基转移酶。我们表明KAN-1是肝癌患者预后的新型预测指标。

项目成果

期刊论文数量(48)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Arii S: "Pathogenic role of kapffer cell actioation in the reperfusion injury of cold-presesved bieer" Transplantation. 58. 1072-1077 (1994)
Arii S:“卡普弗细胞激活在冷保存啤酒再灌注损伤中的致病作用”移植。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Shigeki Arii: "Chemical mediators release and surface marker expression of hepatic macrophages in rats with CC14-induced liver cirrhosis." Life Sciences. 54. 2071-2082 (1994)
Shigeki Arii:“CC14 诱导的肝硬化大鼠肝巨噬细胞的化学介质释放和表面标志物表达。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
W.Zhang: "The role of kupffer cells in the surveillance of tumor growth in the liver." J.Surg.Res.55. 140-146 (1993)
W.Zhang:“库普弗细胞在监测肝脏肿瘤生长中的作用。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Shigeki Arii: "Suppression of the reperfusion injury of cold-preserved livers by Kupffer cell blockade." Transplant. Proc.27. 765-767 (1995)
Shigeki Arii:“通过库普弗细胞阻断来抑制冷保存肝脏的再灌注损伤。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
M.Mise: "Augmented local immunity in theliver by a streptococcal preparation,ok-432,related to antitumor activity of hepatic macrophages." Immunopharmacology. 27. 31-41 (1994)
M.Mise:“通过链球菌制剂 ok-432 增强肝脏的局部免疫力,与肝巨噬细胞的抗肿瘤活性有关。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ARII Shigeki其他文献

ARII Shigeki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ARII Shigeki', 18)}}的其他基金

Study on the molecular diagnosis of metastasis and recurrence and molecular targeted therapy for intractable hepato-pancreatic cancer
难治性肝胰腺癌转移复发的分子诊断及分子靶向治疗研究
  • 批准号:
    20249061
  • 财政年份:
    2008
  • 资助金额:
    $ 4.61万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Multidisciplinary research for molecular mechanism of cancer progression and development of diagnostic and therapeutic tool
癌症进展分子机制的多学科研究及诊断和治疗工具的开发
  • 批准号:
    18209043
  • 财政年份:
    2006
  • 资助金额:
    $ 4.61万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Development of molecular- targeting therapy and prediction of mode of recurrence by analysis of molecular mechanism of invasion and metastasis of hepatocellular carcinoma
肝细胞癌侵袭转移分子机制分析分子靶向治疗发展及复发模式预测
  • 批准号:
    16390375
  • 财政年份:
    2004
  • 资助金额:
    $ 4.61万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Order-made medicine for cancer in the viewpoint of angiogenesis
从血管生成的角度进行癌症定制治疗
  • 批准号:
    14370379
  • 财政年份:
    2002
  • 资助金额:
    $ 4.61万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Study on the improvement of liver injury by controlling sinusoidal cells and spleen
控制肝窦细胞和脾脏改善肝损伤的研究
  • 批准号:
    12470257
  • 财政年份:
    2000
  • 资助金额:
    $ 4.61万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of novel gene therapies in the field of liver surgery
肝脏外科领域新型基因疗法的开发
  • 批准号:
    09557104
  • 财政年份:
    1997
  • 资助金额:
    $ 4.61万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Pathophysiology of the liver and development of a novel therapeutics based on morphological and functional study on hepatic sinusoidal
肝脏的病理生理学以及基于肝窦形态和功能研究的新型疗法的开发
  • 批准号:
    08457322
  • 财政年份:
    1996
  • 资助金额:
    $ 4.61万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

Regulation of zebrafish hematopoiesis by the sinusoidal endothelial cell niche
窦状内皮细胞生态位对斑马鱼造血的调节
  • 批准号:
    10155475
  • 财政年份:
    2017
  • 资助金额:
    $ 4.61万
  • 项目类别:
Regulation of zebrafish hematopoiesis by the sinusoidal endothelial cell niche
窦状内皮细胞生态位对斑马鱼造血的调节
  • 批准号:
    9926235
  • 财政年份:
    2017
  • 资助金额:
    $ 4.61万
  • 项目类别:
Generating Functional Liver Sinusoidal Endothelial Cells from Human Pluripotent Stem Cells
从人类多能干细胞生成功能性肝窦内皮细胞
  • 批准号:
    319198
  • 财政年份:
    2014
  • 资助金额:
    $ 4.61万
  • 项目类别:
    Fellowship Programs
Liver Sinusoidal Endothelial Cell Progenitor Cells (sprocs) and Chronic Liver Disease
肝窦内皮细胞祖细胞 (sprocs) 与慢性肝病
  • 批准号:
    9884512
  • 财政年份:
    2014
  • 资助金额:
    $ 4.61万
  • 项目类别:
Liver Sinusoidal Endothelial Cell Progenitor Cells (sprocs) and Chronic Liver Disease
肝窦内皮细胞祖细胞 (sprocs) 与慢性肝病
  • 批准号:
    10551832
  • 财政年份:
    2014
  • 资助金额:
    $ 4.61万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了